News - MedTech & Diagnostics
Baxter’s digital health data demonstrates patient benefits and cost-savings on World Kidney Day

MedTech News: Baxter Healthcare, a global leader in dialysis care, announced today its support for World Kidney Day 2021 “Living Well with Kidney Disease” with new economic modelling in support of remote patient management technology for home-based peritoneal dialysis.
The Baxter sponsored paper “Cost Consequence Analysis of Remote Patient Management with HomeChoice Claria with Sharesource Platform for Automated Peritoneal Dialysis Patients in the Australian Setting” published by the International Society for Pharmacoeconomics and Outcomes
Research (ISPOR) estimated a reduction in hospital episodes and potential financial savings to the healthcare system from Baxter Sharesource remote patient management technology for APD.
Over a 12-month period, for each 100 people on two-way remote patient monitoring by Sharesource while undergoing APD, the estimated reduction in hospitals episodes is 36 and potential savings is approximately $AU324,488 compared to traditional APD.
In support of the World Kidney Day organisation and “Living Well with Kidney Disease”, Baxter Australia General Manager, Steven Flynn, said increased education and awareness about kidney disease was an important part of helping patients to live well.
“Baxter Healthcare is proud to support the World Kidney Day organisation and the Living Well with Kidney Disease campaign,” Mr Flynn said.
“Kidney disease is a growing social, economic and health problem globally. As a local Australian manufacturer of dialysis solutions, Baxter is all too aware of the impacts of kidney disease on patients, their families, clinicians and the sustainability of the healthcare system.”
“Collaboration among patient groups, healthcare providers, policy makers and industry is needed to increase education, awareness and patient empowerment to live well with kidney disease.”
Human Resources
Merck puts the ‘family’ in workplace as fertility survey exposes gaps
Merck has announced the results of its Fertility Futures Survey of 1,500 Australians aged 18 to 35, revealing significant gaps […]
MoreNews - MedTech & Diagnostics
Australia has a new genomics framework. But will patients see the difference?
The government has released the National Health Genomics Policy Framework and Implementation Plan 2026–2030, jointly developed by the federal and […]
MoreNews - Pharmaceuticals
PCFA condemns funding axe and demands Prime Minister intervene
The Prostate Cancer Foundation of Australia (PCFA) has condemned the Albanese Government’s decision to end funding for its national Prostate […]
MoreNews - Pharmaceuticals
Sanofi’s clinical-trial push hits a GP reality check
New research from Sanofi presented at the Australian Public Health Conference this week points to an addressable opportunity to increase […]
More